Inhibition of primate spinothalamic tract neurons by spinal glycine and GABA is modulated by guanosine 3',5'-cyclic monophosphate

Journal of Neurophysiology

Volumn 81, Issue 3, 1999, Pages 1095-1103

  Lin, Qing ^a   Wu, Jing ^a   Peng, Yuan Bo ^a,b   Cui, Minglei ^a   Willis, William D ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 8 BROMO CYCLIC AMP; AMINO ACID RECEPTOR; CYCLIC GMP; GLYCINE;

ANIMAL CELL; ARTICLE; DOWN REGULATION; MECHANICAL STIMULATION; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; SECOND MESSENGER; SENSITIZATION; SIGNAL TRANSDUCTION; SPINAL CORD DORSAL HORN; SPINOTHALAMIC TRACT; SYNAPTIC INHIBITION;

EID: 0032977387     PISSN: 00223077     EISSN: None     Source Type: Journal    
DOI: 10.1152/jn.1999.81.3.1095     Document Type: Article

References (61)

1. BARINGA, M. Is nitric oxide the "retrograde messenger"? Science 254: 1296-1297, 1991.
2. BAUMANN, T. K., SIMONE, D. A., SHAIN, C. N., AND LAMOTTE, R. H. Neurogenic hyperalgesia: the search for the primary cutaneous afferent fibers that contribute to capsaicin-induced pain and hyperalgesia. J. Neurophysiol. 66: 212-227, 1991.
3. A receptor function is modulated by cyclic GMP. Brain Res. Bull. 37: 67-72, 1995.
4. BREDT, D. S. AND SNYDER, S. H. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc. Natl. Acad. Sci. USA 86: 9030-9033, 1989.
5. BREDT, D. S. AND SNYDER, S. H. Isolation of nitric oxide synthase, a calmodulin-requiring enzyme. Proc. Natl. Acad. Sci. USA 87: 682-685, 1990.
6. BUTT, E., NOLTE, C., SCHULZ, S., BELTMAN, J., BEAVO, J. A., JASTORFF, B., AND WALTER, U. Analysis of the functional role of cGMP-dependent protein kinase in intact human platelets using a specific activator 8-para-chlorophenylthio-cGMP. Biochem. Pharmacol. 43: 2591-2600, 1992.
7. CHUNG, J. M., SURMEIER, D. J., LEE, K. H., SORKIN, L. S., HONDA, C. N., TSONG, Y., AND WILLIS, W. D. Classification of primate spinothalamic and somatosensory thalamic neurons based on cluster analysis. J. Neurophysiol. 56: 308-327, 1986.
8. DAVIES, S. N. AND LODGE, D. Evidence for involvement of N-methylaspartate receptors in "wind-up" of class 2 neurones in the dorsal horn of the rat. Brain Res. 424: 402-406, 1987.
9. DOUGHERTY, P. M., PALEČEK, J., PALEČKOVÁ, V., AND WILLIS, W. D. The role of NMDA and non-NMDA excitatory amino acid receptors in the excitation of primate spinothalamic tract neurons by mechanical, chemical, thermal, and electrical stimuli. J. Neurosci. 12: 3025-3041, 1992a.
10. DOUGHERTY, P. M., PALEČEK, J., PALEČKOVÁ, V., AND WILLIS, W. D. Neurokinin 1 and 2 antagonists attenuate the responses and NK1 antagonists prevent the sensitization of primate spinothalamic tract neurons after intradermal capsaicin. J. Neurophysiol. 72: 1464-1475, 1994.
11. DOUGHERTY, P. M., PALEČEK, J., PALEČKOVÁ, V., AND WILLIS, W. D. Infusion of substance P or neurokinin A by microdialysis alters responses of primate spinothalamic tract neurons to cutaneous stimuli and to iontophoretically released excitatory amino acids. Pain 61: 411-425, 1995.
12. DOUGHERTY, P. M., SLUKA, K. A., SORKIN, L. S., WESTLUND, K. N., AND WILLIS, W. D. Neural changes in acute arthritis in monkeys. I. Parallel enhancement of responses of spinothalamic tract neurons to mechanical stimulation and excitatory amino acids. Brain Res. Rev. 17: 1-13, 1992b.
13. DOUGHERTY, P. M. AND WILLIS, W. D. Enhancement of spinothalamic neuron responses to chemical and mechanical stimuli following combined microiontophoretic application of N-methyl-D-aspartic acid and substance P. Pain 47: 85-93, 1991a.
14. DOUGHERTY, P. M. AND WILLIS, W. D. Modification of the responses of primate spinothalamic neurons to mechanical stimulation by excitatory amino acids and an N-methyl-D-aspartate antagonist. Brain Res. 542: 15-22, 1991b.
15. DOUGHERTY, P. M. AND WILLIS, W. D. Enhanced responses of spinothalamic tract neurons to excitatory amino acids accompany capsaicin-induced sensitization in the monkey. J. Neurosci. 12: 883-894, 1992.
16. GAMSE, R., MOLNAR, A., AND LEMBECK, F. Substance P release from spinal cord slices by capsaicin. Life Sci. 25: 629-636, 1979.
17. GARRY, M. G., ABRAHAM, E., HARGREAVES, K. M., AND AANONSEN, L. M. Intrathecal injection of cell-permeable analogs of cyclic 3',5'-guanosine monophosphate produces hyperalgesia in mice. Eur. J. Pharmacol. 260: 129-131, 1994a.
18. GARRY, M. G. AND DAVIS, M. A. Spinal cyclic GMP is hyperalgesic in the rat. Soc. Neurosci. Abstr. 23: 2357, 1997.
19. GARRY, M. G., RICHARDSON, J. D., AND HARGREAVES, K. M. Carrageenan-induced inflammation alters the content of i-cGMP and i-cAMP in the dorsal horn of the spinal cord. Brain Res. 646: 135-139, 1994b.
20. GARTHWAITE, J. AND BALAZS, R. Supersensitivity to the cyclic GMP response to glutamate during cerebellar maturation. Nature 275: 328-329, 1978.
21. GARTHWAITE, J., CHARLES, S. L., AND CHESS-WILLIAMS, R. Endothelium-derived relaxing factors released on activation of NMDA receptors suggests role as intracellular messenger in the brain. Nature 336: 385-388, 1988.
22. GARTHWAITE, J., SOUTHAM, E., BOULTON, C. L., NIELSEN, E. B., SCHMIDT, K., AND MAYER, B. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Mol. Pharmacol. 48: 184-188, 1995.
23. HALEY, J. E., SULLIVAN, A. F., AND DICKENSON, A. H. Evidence for spinal N-methyl-D-aspartate receptor involvement in prolonged chemical nociception in the rat. Brain Res. 518: 218-226, 1990.
24. HARTELL, N. A. cGMP acts within cerebellar Purkinje cells to produce long term depression via mechanisms involving PKC and PKG. Neuroreport 5: 833-836, 1994a.
25. HARTELL, N. A. Induction of cerebellar long-term depression requires activation of glutamate metabotropic receptors. Neuroreport 5: 913-916, 1994b.
26. ITO, M. AND KARACHOT, L. Messengers mediating long-term desensitization in cerebellar Purkinje cells. Neuroreport 1: 129-132, 1990.
27. ITO, M. AND KARACHOT, L. Protein kinases and phosphatase inhibitors mediating long-term desensitization of glutamate receptors in cerebellar Purkinje cells. Neurosci. Res. 14: 27-38, 1992.
28. A receptors. Mol. Brain Res. 42: 131-134, 1996.
29. A receptor phosphorylation: multiple sites, actions and artifacts. Trends Pharmacol. Sci. 12: 84-87, 1991.
30. A receptor: role of desensitization. Mol. Pharmacol. 41: 1116-1123, 1992.
31. LEREA, L. S., BUTLER, L. S., AND MCNAMARA, J. O. NMDA and non-NMDA receptor-mediated increase of c-fos mRNA in dentate gyrus neurons involves calcium influx via different routes. J. Neurosci. 12: 2973-2981, 1992.
32. LIN, Q., PALEČEK, J., PALEČKOVÁ, V., PENG, Y. B., WU, J., CUI, M., AND WILLIS, W. D. Nitric oxide mediates the central sensitization of primate spinothalamic tract neurons. J. Neurophysiol. 81: 000-000, 1999a.
33. A antagonists reduce the inhibition of primate spinothalamic tract neurons produced by stimulation in periaqueductal gray. Brain Res. 654: 286-302, 1994.
34. LIN, Q., PENG, Y. B., AND WILLIS, W. D. Possible role of protein kinase C in the sensitization of primate spinothalamic tract neurons. J. Neurosci. 16: 3026-3034, 1996a.
35. LIN, Q., PENG, Y. B., AND WILLIS, W. D. Inhibition of primate spinothalamic tract neurons by spinal glycine and GABA is reduced during central sensitization. J. Neurophysiol. 76: 1005-1014, 1996b.
36. LIN, Q., PENG, Y. B., AND WILLIS, W. D. The effects of 8-bromo-cGMP on the inhibition of primate spinothalamic neurons produced by stimulation in periaqueductal gray and by activation of spinal glycine and GABA receptors (Abstract). 8th World Congr. Pain, IASP, 1996c, p. 473-474.
37. LIN, Q., PENG, Y. B., AND WILLIS, W. D. Role of GABA receptor subtypes in inhibition of primate spinothalamic tract neurons: difference between spinal and periaqueductal gray inhibition. J. Neurophysiol. 75: 109-123, 1996d.
38. LIN, Q., PENG, Y. B., WU, J., AND WILLIS, W. D. Involvement of cGMP in nociceptive processing by and sensitization of spinothalamic neurons in primates. J. Neurosci. 17: 3293-3302, 1997.
39. LIN, Q., WU, J., PENG, Y. B., CUI, M., AND WILLIS, W. D. Nitric oxide-mediated spinal disinhibition contributes to the sensitization of primate spinothalamic tract neurons. J. Neurophysiol. 81: 000-000, 1999b.
40. LINCOLN, T. M. AND CORNWELL, T. L. Intracellular cyclic GMP receptor proteins. FASEB J. 7: 328-338, 1993.
41. MACDERMOTT, A. B., MAYER, M. L., WESTBROOK, G. L., SMITH, S. J., AND BARKER, J. L. NMDA-receptor activation increases cytoplasmic calcium concentration in cultured spinal cord neurons. Nature 321: 519-522, 1986.
42. MANZONI, O.J.J., FINIELS-MARLIER, F., SASSETTI, I., BLOCKAERT, J., LE PEUCH, C., AND SLADECZEK, F.A.J. The glutamate receptor of the Qp-type activates protein kinase C and is regulated by protein kinase C. Neurosci. Lett. 109: 146-151, 1990.
43. 2+ in mammalian neurons. Trends Pharmacol. Sci. 11: 254-260, 1990.
44. MCDONALD, B. J. AND MOSS, S. J. Differential phosphorylation of intracellular domains of gamma-aminobutyric acid A receptors subunits by calcium/ calmodulin type 2-dependent protein kinase and cGMP-dependent protein kinase. J. Biol. Chem. 269: 18111-18117, 1994.
45. MELLER, S. T., DYKSTRA, C., AND GEBHART, G. F. Production of endogenous nitric oxide and activation of soluble guanylate cyclase are required for N-methyl-D-aspartate-produced facilitation of the nociceptive tail flick reflex. Eur. J. Pharmacol. 214: 93-96, 1992.
46. OKADA, D. Two pathways of cyclic GMP production through glutamate receptor-mediated nitric oxide synthesis. J. Neurochem. 59: 1203-1210, 1992.
47. OTSUKA, M. AND YOSHIOKA, K. Neurotransmitter functions of mammalian tachykinins. Physiol. Rev. 73: 229-308, 1993.
48. RAGOZZINO, D. AND EUSEBI, F. Inhibition of GABA and glycine responses by glutamate in rat hippocampal neurons. Brain Res. 628: 115-120, 1993.
49. - permeation across the Deiteri's neuron membrane by GABA on its cytoplasmic side is abolished by protein kinase C activators. Cell. Mol Neurobiol. 13: 547-558, 1993.
50. A receptor function in the rat cerebral cortex and cerebellar granule cells. Neuroscience 74: 99-105, 1996.
51. SCHMIDT, H.H.H.W., LOHMANN, S. M., AND WALTER, U. The nitric oxide and cGMP signal transduction system: regulation and mechanism of action. Biochim. Biophys. Acta 1178: 153-175, 1993.
52. SCHOEPP, D. D. AND CONN, P. J. Metabotropic glutamate receptors in brain function and pathology. Trends Pharmacol. Sci. 14: 13-20, 1993.
53. SHIBUKI, K. AND OKADA, D. Endogenous nitric oxide release required for long-term synaptic depression in the cerebellum. Nature 349: 326-328, 1991.
54. SLUKA, K. A. AND WILLIS, W. D. The effects of G-protein and protein kinase inhibitors on the behavioral responses of rats to intradermal injection of capsaicin. Pain 71: 165-178, 1997.
55. SORKIN, L. S. AND MCADOO, D. J. Amino acids and serotonin are released into the lumbar spinal cord of the anesthetized cat following intradermal capsaicin injection. Brain Res. 607: 89-98, 1993.
56. SOUTHAM, E. AND GARTHWAITE, J. Comparative effects of some nitric oxide donors on cyclic GMP levels in rat cerebellar slices. Neurosci. Lett. 130: 107-111, 1991.
57. VAELLO, M. L., RUIZ-G'OMEZ, A., LERMA, J., AND MAYOR, F., JR. Modulation of inhibitory glycine receptors by phosphorylation by protein kinase C and cAMP-dependent protein kinase. J. Biol. Chem. 269: 2002-2008, 1994.
58. WALDMAN, S. AND MURAD, F. Cyclic GMP synthesis and function. Pharmacol. Rev. 39: 173-195, 1987.
59. WATLING, K. J. Nonpeptide antagonists herald new era in tachykinin. Trends Pharmacol Sci. 13: 266-269, 1992.
60. A receptor function via coactivation of cGMP-dependent kinase and phosphodiesterase. J. Neurosci. 18: 2342-2349, 1998.
61. A receptors. Neurosci. Lett. 180: 239-242, 1994.